Florian Verrier

Mr. Florian Verrier

ined
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FVFlorian Verrier
Florian Verrier
Sophie Le CoeurSophie Le Coeur
Sophie Le Coeur
TDTristan Delory
Tristan Delory
Women living with HIV (WLHIV) are prone to harbor several high-risk human papillomavirus (HR-HPV) genotypes and to develop cervical cancerous lesions. Data on HPV prevalence in these women are needed to inform immunization programs, especially in Asia where few data are available. We conducted a systematic review and meta-analysis to estimate the prevalence of HPV and HR-HPV cervical infection in WLHIV in Asia and identify possible sources of heterogeneity for HR-HPV carriage. Pooled prevalence and its 95% confidence interval (95CI) were estimated using the inverse-variance weighting method. Linear regression weighted on study size was used to identify sources of heterogeneity. Among 7834 WLHIV (40 studies), the prevalence of HPV infection was 42.6% (95CI, 38.2% to 47.1%), and 34.6% (95CI, 30.3% to 39.1%) harbored HR-HPV genotypes, with significant heterogeneity across countries. In India, Thailand, and China, HPV-16 was the most frequent genotype (10.3%), followed by HPV-52 (5.4%), HPV-58 (5.0%), HPV-18 (4.1%), and HPV-33 (3.3%). In these women, most of whom were receiving antiretroviral therapy, we did not identify determinants of heterogeneity for HR-HPV infection. Our results underline the need for immunization programs based on nonavalent or new generation vaccines to prevent cervical cancer in WLHIV in Asia.

10 March 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
FVFlorian Verrier
Florian Verrier
ALAgathe de Lauzanne
Agathe de Lauzanne
JDJean-Baptiste Niokhhor Diouf
Jean-Baptiste Niokhhor Diouf
AZAndrianirina Zafitsara Zo
Andrianirina Zafitsara Zo
LRLison Ramblière
Lison Ramblière
BGBenoit Garin
Benoit Garin
Vaccination reduces mortality from infectious disease, which is the leading cause of death in children under 5 and bears a particularly high burden in low- and middle-income countries. The Global Vaccine Action Plan (2011–2020) has set a target of 90% vaccine coverage for all vaccines included in national immunization programs by 2020. The objectives of this study were to estimate vaccine coverage among children in Madagascar, Cambodia, and Senegal and to identify the risk factors associated with incomplete vaccination. Using data from a community-based prospective cohort that included all newborn of some areas from 2012 to 2018 in these 3 countries, vaccine coverage was estimated for BCG, hepatitis B, oral polio, pentavalent (targeting diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b), and measles vaccines. Risk factor analysis was performed with logistic regression models to identify correlates of incomplete vaccination. A total of 3606 children were followed up, and vaccine coverage was below the 90% threshold for most vaccines in all countries. Coverage was higher for vaccines recommended at birth and at 6 weeks, while a decrease in coverage for subsequent doses was observed for vaccines requiring several doses (23–47 points). Low birth weight (<2500 g) was an important risk factor for nonvaccination for vaccines recommended at birth in all 3 countries (adjusted odds ratio [95% confidence interval] ranging from 1.93 [1.11–3.38] to 4.28 [1.85–9.37]). Vaccine coverage for common childhood vaccines was lower than World Health Organization recommendations, and multidisciplinary approaches may help to improve vaccine coverage and timeliness.

22 February 2018 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
FVFlorian Verrier
Florian Verrier
CDCatherine Dubois D'ENghien
Catherine Dubois D'ENghien
MGMarion Gauthier‐Villars
Marion Gauthier‐Villars
VBValérie Bonadona
Valérie Bonadona
CFCécile Faure‐Conter
Cécile Faure‐Conter
LGLisa Golmard
Lisa Golmard

19 January 2022 in Journal of Immigrant & Refugee Studies
Verified
Journal Article
Closed access
LGLara Gautier
Lara Gautier
SWStéphanie Nguengang Wakap
Stéphanie Nguengang Wakap
FVFlorian Verrier
Florian Verrier
ÉMÉrica da Silva Miranda
Érica da Silva Miranda
VNVictoria Négré
Victoria Négré
MBMagali Bouchon
Magali Bouchon
Unaccompanied minors (UMs) are children under the age of 18 who settle in a foreign country without a legal representative. In France, many UMs are left unprotected from child welfare services because assessment systems evaluate that they are not minors. In Paris, the non-governmental organization Médecins du Monde (MdM) offers unprotected UMs medical, psychological, and social care. In March 2020, the lockdown policy to contain COVID-19 constrained MdM to adapt its care provision model. This case study sought to answer the following question: how did volunteers and employees of MdM respond to the social and health needs of unprotected UMs during the spring 2020 lockdown in Paris? We analyzed a cohort of 58 UMs for eight weeks of lockdown using secondary quantitative data. We further explored the UMs’ needs and the experience of phone consultations, through 15 interviews with MdM’s program volunteers and employees. Time series showed a steady increase in UMs’ needs. The program’s adapted care provision likely contributed to reducing UMs’ feeling of isolation. It also had several negative consequences for unprotected UMs, volunteers, employees, and Médecins du Monde’s institution. This study highlights the role of non-governmental organizations in providing a particularly vulnerable migrant population – unprotected UMs – care and support, despite operational challenges in crisis times.

16 May 2021 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
FSFrançois Simon
François Simon
BTBriac Thierry
Briac Thierry
TRTioka Rabeony
Tioka Rabeony
FVFlorian Verrier
Florian Verrier
CECaroline Elie
Caroline Elie
FDFrançoise Denoyelle
Françoise Denoyelle

15 August 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
LGLisa Golmard
Lisa Golmard
RVRoseline Vibert
Roseline Vibert
EPElise Pierre-Noël
Elise Pierre-Noël
FVFlorian Verrier
Florian Verrier
CDCatherine Dubois D&Apos;Enghien
Catherine Dubois D&Apos;Enghien
EPEric Pasmant
Eric Pasmant
Background. DICER1 syndrome is an autosomal dominant disorder predisposing to a broad spectrum of malignant and benign neoplasms, caused by germline pathogenic variants (PVs) in the DICER1 gene. We aimed to characterize the clinical features of DICER1 syndrome in a national referral cohort and to estimate neoplasm risk.Materials and Methods. This retrospective study was conducted in a cohort of 945 patients who underwent DICER1 genetic testing at Institut Curie, Paris, using Sanger sequencing from 2012 to 2014 and Next Generation Sequencing from 2015 to 2023.Results. Among 584 index cases evaluated for DICER1 syndrome, 91 (16%) carried a germline DICER1 PV and 31 (5%) harbored only somatic DICER1 PVs. Several tumors that were not previously part of the DICER1 tumor spectrum were identified. ETMR-like brain tumor and testicular Sertoli cell tumor are now recognized as DICER1-related neoplasms, and schwannoma is a strong candidate. The neoplasm risk was estimated in 170 relatives carrying a germline DICER1 PV. The cumulative incidence of malignant neoplasms was 4.8% [95% CI: 2.1% – 9.1%] at 10 years and 15.8% [95% CI: 8.9% – 24.7%] at 50 years. Overall neoplasm risk was significantly higher in females, primarily driven by the higher incidence of multinodular goiter.Conclusion. This large cohort study provides a comprehensive overview of the distribution of neoplasms associated with DICER1 syndrome. Broader genetic testing identified additional DICER1-related neoplasms, and schwannoma emerged as a candidate association. Finally, this study confirms the moderate penetrance of germline DICER1 PVs.